Demystifying a Schedule 1 Classification For CBD

[PrincessM]

There is science behind CBD, even though its usefulness can be dismissed by people who have some influence over people\’s lives in general. This can include school social workers and administrators and psychiatrists. Some examples are that parents of a seven year old girl were taken into custody for four days because they were treating her seizures effectively with CBD oil. School athletes might lose scholarship opportunities for treating seizures with CBD, because its use violates the school\’s drug policy. Or, it might happen that children can\’t enroll in school due also to their use of CBD for treating seizures, which might likewise violate the campus\’ drug use policy.

Due to these scenarios, clarification is needed as to when and how there are misconceptions about CBD and its uses. In the summer of 2019, the Food and Drug Administration, FDA, approved the anti-seizure drug, Epidiolex, which is a CBD medication used to treat thedifficult epileptic cases of Dravet Syndrome, Lennox Gastaut Syndrome and also tuberous sclerosis. Epidiolex is the first CBD based medication to gain FDA approval since cannabis first became a Schedule 1 substance in 1970. This classification means that the medication can be used legally, but with restrictions, for an indicated medical condition. This was also the time when the government began classifying drugs into different categories, or schedules. Even though the Schedule 1 status means that the drug has no medical value, the results from the clinical trials of Epidiolex were convincing enough for the FDA to approve it. This creates a dilemma where people might believe that since a drug is listed as a narcotic, by the Schedule 1 classification, that no research was performed on the medication. This pertains to research done in the United States, because a Schedule 1 status makes research on CBD more difficult to perform. However, some U.S. universities are permitted to research on the cannabis plant.

An example of an American based study was one that took place at Columbia University, which studied the use of CBD as a treatment for glioblastoma. This is the most common form of cancerous brain tumors in adults. The standard and conventional treatment for this comdition is chemotherapy, radiation and surgery. The results of the university study found that CBD induced the death of the cancerous cells, and enhanced their radiosensitivity, but did not affect normal, healthy cells. The CBD seemed to have helped to kill and weaken the cancerous cells, without damaging the healthy, non cancerous cells. In addition, research has been done outside of the United States, which the US government partially funds.

[Author]

Posts